证券代码:001206 证券简称:依依股份 天津市依依卫生用品股份有限公司 2023 年 9 月 22 日投资者关系活动记录表 编号:2023-010 特定对象调研 分析师会议 投资者关 媒体采访 业绩说明会 系活动类 新闻发布会 路演活动 别 现场参观 其他 参与单位 名称及人 详见附件 员姓名 时间 2023 年 9 月 22 日 地点 天津市依依卫生用品股份有限公司会议室 董事会秘书兼财务总监周丽娜 上市公司 证券事务代表张贝贝 参与人员 姓名 证券事务专员杨一木 2023 年 9 月 22 日,公司参会人员通过现场调研的方式与投资者进行了交 流,本次会议纪要如下: 一、参观产品展室 投资者关 二、介绍公司情况 系活动主 三、问答交流环节 要内容介 绍 Q1、通过介绍可以看到依依是一家十分值得尊敬的公司,从财务状况来 看,公司在 2023 年上半年的营业收入下降的原因是什么? 答:2023 年上半年公司实现营业收入 6.28 亿元,同比下降 14.06%,相比 一季度降幅 19.51%进一步收窄;实现归母净利润为 4,496.45 万元,同比下降 31.13%;扣非后归母净利润为 4,332.73 万元 ...

Group 1: Event Announcement - Tianjin Yiyi Hygiene Products Co., Ltd. will participate in the "2023 Annual Half-Year Report Performance Briefing and Investor Online Reception Day" on September 5, 2023 [2] - The event will be conducted online, allowing investors to join via the "Panorama Roadshow" website or related platforms [2] - The online interaction will take place from 13:30 to 16:50 on the specified date [2] Group 2: Company Representatives - The company's Chairman and General Manager, Mr. Gao Fuzhong, and the Secretary of the Board and Chief Financial Officer, Ms. Zhou Lina, will be present to communicate with investors [2] - They will address topics such as company performance, governance, development strategy, operational status, and sustainable development [2] Group 3: Investor Engagement - Investors are encouraged to submit questions via the company's securities department email by September 4, 2023, at 12:00 [2] - Commonly asked questions will be addressed during the online reception day [2] - The company aims to enhance communication and respect for investors through this initiative [2]

证券代码：001206 证券简称：依依股份 天津市依依卫生用品股份有限公司 2023 年 8 月 25 日-8 月 26 日投资者关系活动记录表 编号：2023-008 特定对象调研 分析师会议 投 资 者 关 媒体采访 业绩说明会 系 活 动 类 新闻发布会 路演活动 别 现场参观 其他 参 与 单 位 名 称 及 人 详见附件 员姓名 时间 2023 年 8 月 25 日-8 月 26 日 地点 天津市依依卫生用品股份有限公司会议室（线上会议方式进行） 董事会秘书兼财务总监周丽娜 上 市 公 司 参 与 人 员 证券事务代表张贝贝 姓名 证券事务专员杨一木 2023 年 8 月 25 日-26 日，公司参会人员通过线上会议方式与投资者进行了 交流，本次会议纪要如下： 投 资 者 关 一、董事会秘书兼财务总监周丽娜女士简要总结公司半年度经营情况 系 活 动 主 （一）销售方面：2023 年上半年公司实现营业收入 6.28 亿元，同比下 要 内 容 介 降 14.06%，相比一季度降幅 19.51%进一步收窄。营业收入按销售区域划 绍 分，境内收入 4,172 万元，同比增长 40.96%，主要系无纺布的收入 ...

天津市依依卫生用品股份有限公司 2023 年半年度报告全文 天津市依依卫生用品股份有限公司 2023 年半年度报告 2023 年 8 月 1 天津市依依卫生用品股份有限公司 2023 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人高福忠、主管会计工作负责人周丽娜及会计机构负责人(会计 主管人员)肖爽声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本半年度报告涉及的未来发展规划和经营目标等前瞻性陈述，属于公司 计划性事务，不构成对投资者的实质承诺，请投资者及相关人士对此保持足 够的风险认识，理解计划、预测与承诺之间的差异，注意投资风险。 公司已在本报告中详细阐述公司可能存在的风险，请查阅本报告中第三 节"管理层讨论与分析"之十"公司面临的风险和应对措施"。敬请广大投 资者注意投资风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 | 目录 | | --- | | 第一节 | 重 ...

证券代码：001206 证券简称：依依股份 天津市依依卫生用品股份有限公司 2023 年 5 月 19 日投资者关系活动记录表 编号：2023-007 特定对象调研 分析师会议 投 资 者 关 媒体采访 业绩说明会 系 活 动 类 新闻发布会 路演活动 别 现场参观 其他 西部证券 陈腾曦 西部证券 黄羽沁 参 与 单 位 名 称 及 人 东方基金 郭晓慧 员姓名 中融基金 范鹏程 海富通基金 赵晨凯 时间 2023 年 5 月 19 日（周五）上午 9：30-11：00 地点 天津市依依卫生用品股份有限公司会议室 董事会秘书兼财务总监周丽娜 上 市 公 司 参 与 人 员 证券事务代表张贝贝 姓名 证券事务专员杨一木 投 资 者 关 2023 年 5 月 19 日，公司参会人员通过现场调研的方式与投资者进行 系 活 动 主 了交流，本次会议纪要如下： 要 内 容 介 一、参观产品展室 绍 二、介绍公司情况 三、问答交流环节 Q1、能否解析一下一季度的销售情况？ 2023 年一季度实现营业收入 2.84 亿元，同比下降 19.51%，主要系部分客 户调整库存、订单减少所致。按主要销售区域看，北美一季度销售额 ...

Financial Performance - The company's revenue for Q1 2023 was ¥283,766,177.08, representing a decrease of 19.51% compared to ¥352,564,316.63 in the same period last year[4] - The net profit attributable to shareholders was a loss of ¥2,254,684.67, a decline of 112.31% from a profit of ¥18,319,381.27 in Q1 2022[4] - Basic and diluted earnings per share were both -¥0.02, down 114.29% from ¥0.14 in the same period last year[4] - Total operating revenue for Q1 2023 was ¥283,766,177.08, a decrease of 19.5% compared to ¥352,564,316.63 in Q1 2022[21] - Net profit for Q1 2023 was a loss of ¥2,254,684.67, compared to a profit of ¥18,319,381.27 in Q1 2022, representing a significant decline[22] Cash Flow - The net cash flow from operating activities increased by 25.53% to ¥72,504,302.64, compared to ¥57,757,154.15 in the previous year[4] - Cash inflow from operating activities totaled ¥368,936,139.52, down 13% from ¥423,257,151.90 in the previous period[24] - Cash outflow from operating activities decreased to ¥296,431,836.88, a reduction of 18.9% compared to ¥365,499,997.75 in the previous period[24] - The net increase in cash and cash equivalents for the current period is ¥123,247,870.86, compared to a net decrease of ¥93,651,162.63 in the previous period[25] - The ending balance of cash and cash equivalents is ¥469,288,173.65, significantly higher than ¥124,930,263.33 at the end of the previous period[25] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥1,987,905,209.60, a decrease of 1.53% from ¥2,018,789,859.02 at the end of the previous year[4] - Total liabilities decreased to ¥180,222,491.50 in Q1 2023 from ¥208,852,456.25 in Q1 2022, a reduction of 13.8%[20] - The company's total equity as of Q1 2023 was ¥1,807,682,718.10, down from ¥1,809,937,402.77 in the previous year[20] Investment and Income - The company reported an increase in investment income to ¥13,831,690.03, up 271.94% from ¥3,718,776.29 in Q1 2022[11] - The financial expenses surged by 270.55% to ¥5,696,700.57, primarily due to increased exchange rate losses[11] - The company received government subsidies amounting to ¥2,056,968.74, contributing to the increase in other income[6] - Cash inflow from investment activities amounted to ¥335,707,073.83, up 22.5% from ¥274,074,461.88 in the previous period[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 16,041[13] - The largest shareholder, Gao Fuzhong, holds 31.00% of the shares, totaling 40,936,245 shares[13] - The top ten shareholders include Lu Junmei with a holding of 12.06% (15,928,500 shares) and Gao Jian with 6.03% (7,964,248 shares)[14] - The total number of shares held by the top ten shareholders represents a significant portion of the company's equity, indicating concentrated ownership[14] Research and Development - Research and development expenses increased to ¥6,097,131.65 in Q1 2023, up from ¥5,056,062.57 in the same period last year, reflecting a growth of 20.6%[22] Strategic Initiatives - The company is focusing on long-term development in the pet industry through strategic investments[16] - The company plans to establish a partnership with Shanghai Qiaobei Investment Management Partnership, contributing RMB 10 million, which represents 47.619% of the total investment of RMB 21 million[16] - The company has signed relevant partnership agreements as of the end of the reporting period[16] Audit Information - The company did not undergo an audit for the first quarter report[26]

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2022, representing a year-on-year increase of 15%[16]. - The net profit attributable to shareholders was RMB 150 million, an increase of 10% compared to the previous year[16]. - The company's operating revenue for 2022 was ¥1,516,338,244.32, representing a 15.75% increase compared to ¥1,310,016,883.16 in 2021[21]. - The net profit attributable to shareholders for 2022 was ¥150,545,118.06, a 31.96% increase from ¥114,085,702.46 in 2021[21]. - The net cash flow from operating activities surged to ¥201,067,294.59, marking a significant increase of 943.26% from ¥19,272,907.30 in 2021[21]. - Basic and diluted earnings per share for 2022 were both ¥1.14, an increase of 18.75% from ¥0.96 in 2021[21]. - The company anticipates a revenue growth of 20% for 2023, driven by new product launches and market expansion efforts[16]. - The company achieved a total operating revenue of ¥1,516,338,244.32 in 2022, representing a year-on-year growth of 15.75%[69]. - The net profit attributable to shareholders reached ¥150,545,118.06, marking a year-on-year increase of 31.96%[69]. Market Expansion and Strategy - The company aims to expand its market presence in Southeast Asia, targeting a 25% increase in market share by 2025[16]. - New product lines, including eco-friendly hygiene products, are expected to launch in Q2 2023, with projected sales of RMB 200 million in the first year[16]. - The company is actively seeking merger and acquisition opportunities to strengthen its strategic development projects in the pet industry[119]. - The company plans to increase its domestic market share by integrating sales resources and marketing channels, capitalizing on the growing pet care market in China[122]. - A strategic acquisition of a local competitor is in progress, which is anticipated to enhance production capacity by 30% and reduce costs by 10%[197]. Research and Development - The company has invested RMB 50 million in R&D for innovative hygiene technologies, aiming for a 30% improvement in product efficiency[16]. - The company reported a significant increase in R&D expenses by 126.00% to 20.30 million yuan, reflecting enhanced product development efforts[83]. - The company's R&D investment increased by 126% from 8,983,590.99 CNY in 2021 to 20,302,812.98 CNY in 2022, representing 1.34% of total revenue[85]. - The number of R&D personnel rose by 94.23% from 52 in 2021 to 101 in 2022, with a significant increase in the proportion of R&D staff from 3.62% to 7.00%[85]. Customer and Market Insights - User data indicates a growth in active customers by 20%, reaching 1.5 million by the end of 2022[16]. - The company’s export share of pet disposable hygiene products was 38.13% in 2022, showing a stable growth trend in market share[51]. - The average annual consumption per dog reached 2,882 yuan in 2022, a 9.4% increase from 2021, while for cats it was 1,883 yuan, up 3.1% from the previous year, reflecting rising consumer spending in the pet sector[62]. - The company has established a strong market position in the pet hygiene product sector, with over 20 years of industry experience[53]. Risk Management - Risks associated with supply chain disruptions and regulatory changes have been identified, with mitigation strategies in place[4]. - The company faces risks from raw material price fluctuations, as direct material costs constitute over 80% of its main business costs[125]. - The company is exposed to exchange rate fluctuations, as its products are primarily exported and priced in USD, which may affect profitability[128]. Corporate Governance - The company held 3 shareholder meetings, 9 board meetings, and 7 supervisory board meetings during the reporting period, complying with relevant laws and regulations[135]. - The board consists of 12 directors, including 4 independent directors, representing one-third of the total[136]. - The company has established a comprehensive internal audit system, with the internal audit department reporting directly to the board's audit committee[138]. - The company emphasizes transparency and timely information disclosure, ensuring that all investors have equal access to information[137]. Shareholder Engagement and Remuneration - The total remuneration for directors, supervisors, and senior management in 2022 amounted to 5.2634 million yuan[159]. - The remuneration policy for directors and senior management is determined by the board's remuneration and assessment committee, requiring approval from the board and shareholders[155]. - The company has a structured approach to remuneration, ensuring alignment with performance and shareholder interests[155]. - The company ensures equal treatment of all shareholders, particularly protecting the rights of minority shareholders[136]. Social Responsibility - The company donated 2 million yuan to the Tianjin Red Cross in January 2022 and provided masks worth over 100,000 yuan to local organizations[189]. - In May 2022, the company contributed 1 million yuan to support key poverty alleviation counties in paired assistance regions[190]. - The company has consistently fulfilled its tax obligations, emphasizing legal compliance and timely payment of taxes since its establishment[192].